Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunityAndrea Ravelli, Daniele Generali, Massimo Martino et al.|Expert Review of Anticancer Therapy|2015Cited by 12
Acute leukemia following a previous malignancy: do acute lymphoid leukemia and acute myeloid leukemia have common risk factors?Livio Pagano, F Mandelli, Alessandro Pulsoni et al.|The Hematology Journal|2000Cited by 10
Survival in Patients With Sentinel Node–Positive Melanoma With Extranodal ExtensionAndrea Maurichi, Mario Santinami, Francesco Barretta et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 7
Impact of CD34+ Cell Dose on Clinical Outcomes after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from Haploidentical Donors in AML Patients. a Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Mohamad Mohty, Myriam Labopin et al.|Transplantation and Cellular Therapy|2020Cited by 0
MRD Status Impact on Secondary Acute Myeloid Leukemia Outcomes after Allogeneic Hematopoietic Cell Transplantation. A Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Arnon Nagler, Myriam Labopin et al.|Transplantation and Cellular Therapy|2021Cited by 0